三年累亏40亿,荣昌生物资产负债率同增26个百分点

财中社
11 Apr

在不可控因素的影响之下,创新药上市公司荣昌生物(688331/09995)股价也受到影响,4月7日收盘跌6.35%,不过之后四个交易日快速收复失地,并再创近期新高。从2025年1月低点算起,公司股价至今已上涨106.55%,4月11日收盘报46.34元,总市值252亿元。天风证券研报指出,关税对创新药影响很小:关税影响的是采购成本,创新药如果只考虑生产成本,平均毛利率 85%以上,成本端的变化影响...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10